Infectious Diseases: Antiviral Wolbachia Limits Dengue in Malaysia

Ewa Chrostek; Gregory D D Hurst; Elizabeth A McGraw

doi:10.1016/j.cub.2019.11.046

Infectious Diseases: Antiviral Wolbachia Limits Dengue in Malaysia

Curr Biol. 2020 Jan 6;30(1):R30-R32. doi: 10.1016/j.cub.2019.11.046.

Authors

Ewa Chrostek¹, Gregory D D Hurst², Elizabeth A McGraw³

Affiliations

¹ Institute of Integrative Biology, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK. Electronic address: echrostek@liv.ac.uk.
² Institute of Integrative Biology, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK.
³ Department of Entomology, Center for Infectious Disease Dynamics, Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA 16802, USA. Electronic address: bethmcgraw@gmail.com.

PMID: 31910374
DOI: 10.1016/j.cub.2019.11.046

Abstract

Vector-borne viral diseases pose an urgent public health challenge, particularly in the tropics. Field releases of mosquitoes carrying bacterial symbionts that reduce vector competence are ongoing in Kuala Lumpur, Malaysia. Early results show that wAlbB Wolbachia can persist in mosquitoes in urban settings and decrease dengue incidence in humans.

Publication types

Comment

MeSH terms

Aedes*
Animals
Antiviral Agents*
Dengue Virus*
Dengue* / transmission
Humans
Malaysia
Mosquito Vectors
Wolbachia*

Substances

Antiviral Agents